SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)][Amend]
SEC Accession No. 0001019687-14-003529
Filing Date
2014-09-10
Accepted
2014-09-10 16:15:20
Documents
10
Filing Date Changed
2014-09-10

Document Format Files

Seq Description Document Type Size
1 10-12G/A vg_1012ga.htm 10-12G/A 1942911
2 CERTIFICATE OF AMENDMENT vg_1012ga-ex0309.htm EX-3.9 10887
3 CERTIFICATE OF RESTATEMENT AND INTEGRATION vg_1012ga-ex0313.htm EX-3.13 13873
4 VG LIFE SCIENCES, INC. AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF SERIES vg_1012ga-ex0314.htm EX-3.14 29151
5 CONSULTING AGREEMENT vg_1012ga-ex10128.htm EX-10.128 43447
6 CONVERTIBLE PROMISSORY NOTE vg_1012ga-ex10129.htm EX-10.129 128240
7 CONVERTIBLE PROMISSORY NOTE vg_1012ga-ex10130.htm EX-10.130 128647
8 FIRST AMENDMENT TO THE CONVERTIBLE PROMISSORY NOTE vg_1012ga-ex10131.htm EX-10.131 6648
9 FIRST AMENDMENT TO THE CONVERTIBLE PROMISSORY NOTE vg_1012ga-ex10132.htm EX-10.132 6676
10 GRAPHIC image_001.jpg GRAPHIC 7280
  Complete submission text file 0001019687-14-003529.txt   2321820
Mailing Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101
Business Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101 805-879-9000
VG Life Sciences, Inc. (Filer) CIK: 0001091326 (see all company filings)

IRS No.: 330814123 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-12G/A | Act: 34 | File No.: 000-26875 | Film No.: 141096048
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1